Gilmartin Capital is a venture capital firm that invests in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. The firm focuses on opportunities beyond proof of concept in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors.

Gilmartin Capital

We invest in entrepreneurs targeting platforms that influence large or underserved diseases, technologies that accelerate and expand scientific discovery, and solutions that impact the cost, site and delivery of care. Our focus is on opportunities that are beyond proof of concept and poised for more significant development and growth in the Medical Device, Life Science Tool, Diagnostic and Digital Health sectors. 

The investing landscape is long on capital and short on insight. Our value extends beyond capital. We possess extensive domain expertise in areas such as strategy, market assessment, and capital markets advisory. Our passion is to avail our experience and network to help you solve problems, drive scientific discovery, help patients and grow. For over two decades, we have amassed a propriety expert network consisting of key opinion leaders across multiple therapeutic verticals and technical specialties, and best-in-class operators in various operational, scientific, and financial areas.  In fact, the majority of our fund capital comes from operators like you. The founding partners have decades of experience analyzing and advising healthcare technology companies. We do the math! We want to help you advance your vision.

Gilmartin Capital LLC

Gilmartin Capital is pleased to announce our participation in Kestra Medical Technologies, Inc.’s oversubscribed financing. We are excited to partner with Kestra in protecting at-risk patients with its modern Wearable Cardioverter Defibrillator (WCD). Kestra’s differentiated ASSURE cardiac recovery system can disrupt the existing $1 billion WCD market, catalyze market acceleration and play an increasingly important role in heart recovery. 

Official press release: https://lnkd.in/g9DqcBXQ

Gilmartin Capital is pleased to announce our participation in the Series G financing for Insightec. We are excited to partner with Insightec to expand incisionless neurosurgery and improve care for patients suffering from movement disorders, such as essential tremor and Parkinson’s disease.
 
Much is known about the function and electrical conductivity of the heart, but the brain remains more mechanistically elusive. We believe the intersection of targeted brain mapping paired with precise, incisionless surgery has great promise in the future.

Official press release: https://lnkd.in/gfT2cgNs

Gilmartin Capital is excited to welcome Stephen K. to the firm as an Associate. Stephen joins us from Bain where he worked in the firm’s private equity due diligence practice in the area of Healthcare. We are excited for Stephen to continue our mission to help entrepreneurs solve problems, drive scientific discovery, help patients and grow.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 29, 2024 9:41 AM	80f47c1c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 29, 2024 11:47 AM	422e0e37
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 29, 2024 9:41 AM	1b9e8cd5
translate crunchbase fundingrounds	general
peers	general	Jul 29, 2024 9:41 AM	438723f6
news basic	general	Jul 29, 2024 9:41 AM	483390ef
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

GILM

COM:GILMARTINCAP

Gilmartin Capital